Affiliation: Eli Lilly and Company
- Weight change and atypical antipsychotic treatment in patients with schizophreniaB Jones
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Ind 46285, USA
J Clin Psychiatry 62:41-4. 2001..Weight gain interventions, including behavioral modifications, show promise in controlling or reducing weight in patients treated with antipsychotics...
- The efficacy of a rapid-acting intramuscular formulation of olanzapine for positive symptomsB Jones
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA
J Clin Psychiatry 62:22-4. 2001..These results suggest that intramuscular olanzapine has positive symptom efficacy early in the course of treatment and may provide a smooth transition to maintenance therapy with oral olanzapine...